PND59 - COST EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH MULTIPLE SCLEROSIS IN GREECE
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2025
https://www.valueinhealthjournal.com/article/S1098-3015(18)35327-0/fulltext
Title :
PND59 - COST EFFECTIVENESS ANALYSIS OF ALEMTUZUMAB AS A TREATMENT OPTION FOR PATIENTS WITH MULTIPLE SCLEROSIS IN GREECE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35327-0&doi=10.1016/j.jval.2018.09.2025
First page :
Section Title :
Open access? :
No
Section Order :
1378